Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$6.69 - $13.45 $2,676 - $5,380
-400 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$6.53 - $10.72 $54,362 - $89,244
-8,325 Reduced 95.42%
400 $4,000
Q1 2018

Oct 11, 2019

SELL
$16.68 - $22.07 $155,290 - $205,471
-9,310 Reduced 51.62%
8,725 $149,000
Q3 2017

Oct 11, 2019

SELL
$15.41 - $32.17 $67,804 - $141,548
-4,400 Reduced 19.61%
18,035 $317,000
Q2 2017

Oct 11, 2019

BUY
N/A
8,650 Added 62.75%
22,435 $745,000
Q1 2017

Oct 11, 2019

SELL
N/A
-17,554 Reduced 56.01%
13,785 $442,000
Q4 2016

Oct 11, 2019

SELL
N/A
-4,233 Reduced 11.9%
31,339 $1.14 Million
Q3 2016

Oct 11, 2019

BUY
N/A
5,050 Added 16.55%
35,572 $1.64 Million
Q2 2016

Oct 11, 2019

BUY
N/A
2,527 Added 9.03%
30,522 $1.53 Million
Q1 2016

Oct 11, 2019

BUY
N/A
27,995
27,995 $1.5 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Stonehage Fleming Financial Services Holdings LTD Portfolio

Follow Stonehage Fleming Financial Services Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehage Fleming Financial Services Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stonehage Fleming Financial Services Holdings LTD with notifications on news.